Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Down – What’s Next?

Shares of Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY) gapped down before the market opened on Wednesday . The stock had previously closed at $26.71, but opened at $25.50. Chugai Pharmaceutical shares last traded at $26.8525, with a volume of 5,682 shares trading hands.

Chugai Pharmaceutical Price Performance

The stock has a 50 day simple moving average of $25.21 and a 200-day simple moving average of $24.10. The firm has a market cap of $87.84 billion, a PE ratio of 33.36 and a beta of 0.63.

Chugai Pharmaceutical (OTCMKTS:CHGCY) last issued its quarterly earnings results on Friday, October 24th. The company reported $0.23 earnings per share for the quarter. The firm had revenue of $2.26 billion during the quarter. Chugai Pharmaceutical had a return on equity of 20.63% and a net margin of 32.74%. As a group, equities analysts predict that Chugai Pharmaceutical Co., Ltd. Unsponsored ADR will post 0.74 EPS for the current fiscal year.

About Chugai Pharmaceutical

Chugai Pharmaceutical Co, Ltd. is a Japan-based biopharmaceutical company headquartered in Tokyo that focuses on the discovery, development, manufacture and marketing of prescription medicines. The company develops both biologics and small-molecule therapies, with particular emphasis on oncology and immunology as well as treatments for bone and metabolic disorders. Chugai’s activities span the full drug lifecycle from early research and clinical development through regulatory approval, manufacturing and post-marketing support.

Chugai is known for its research-driven approach and its work on monoclonal antibodies and other biologic therapeutics.